InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,399.22
(
-0.51%
)
US TECH 100
18,536.80
(
1.12%
)
Dow Jones
39,935.07
(
0.00%
)
Brent Oil
81.15
(
-0.48%
)
Bitcoin
67,261.86
(
2.24%
)
Post# of 252689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: None

Friday, 03/02/2018 6:09:42 PM

Friday, March 02, 2018 6:09:42 PM

Post# of 252689
Cancer immunotherapy biotech Unum Therapeutics files for an $86 million IPO
https://www.renaissancecapital.com/IPO-Center/News/55325/Cancer-immunotherapy-biotech-Unum-Therapeutics-files-for-an-$86-million-IPO

Unum Therapeutics, which is developing antibody-coupled T cell immunotherapies for cancers, filed on Friday with the SEC to raise up to $86 million in an initial public offering.

The Cambridge, MA-based company was founded in 2014 and plans to list on the Nasdaq under the symbol UNUM. Unum Therapeutics filed confidentially on November 3, 2017. Morgan Stanley and Cowen & Company are the joint bookrunners on the deal. No pricing terms were disclosed.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up